AGP Executive Report
Last update: 28 minutes agoConflict and Care: A Russian strike hit a hospital complex in Kharkiv, injuring 73 patients, medical workers and nearby residents during a wider overnight assault on Ukraine. Heart Health: Updated U.S. guidelines recommend measuring lipoprotein(a), an inherited risk factor for heart disease and stroke, at least once in adulthood; the test must be ordered separately from a standard cholesterol panel. Drug Research: Teva plans to stop its Phase II trial of an experimental multiple system atrophy treatment after an interim review found little chance it would meet its main goal. No safety concerns were reported. Reproductive Medicine: New findings are raising questions about the risks and benefits of “three-parent IVF,” developed to prevent inherited mitochondrial disease, as Australia prepares to begin a national program. Outbreak Readiness: Zimbabwe launched a three-year, $14.33 million initiative to strengthen disease surveillance, laboratory testing and emergency preparedness. Cancer Access: Max Healthcare says revised government reimbursement rates made some high-cost chemotherapy drugs unviable to supply, contributing to a drop in oncology’s share of inpatient revenue and raising concerns about treatment access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
